<table border="1" id="id_b8c88d02-a86a-4e04-8054-1b86e3238467" rules="all" width="0.000" xmlns="urn:hl7-org:v3" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance">
<caption id="id_47755698-c743-4be6-be4a-77ebe06ec68e">Table 6: Predicted Drug Interactions with Didanosine Delayed-Release</caption>
<col></col>
<col></col>
<col></col>
<tbody>
<tr id="id_d4b103b8-03a2-43ff-adb9-00d69b352864" stylecode="Toprule">
<td align="center" valign="top">
<content stylecode="bold">Drug or Drug Class</content>
</td>
<td align="center" stylecode="Toprule" valign="top">
<content stylecode="bold">Effect</content>
</td>
<td align="center" valign="top">
<content stylecode="bold">Clinical Comment</content>
</td>
</tr>
<tr id="id_5a517fa7-808b-4e09-b9ea-a2f4c5d7eb1a">
<td align="left" valign="top">Drugs that may cause pancreatic toxicity</td>
<td align="center" valign="top">↑ risk of pancreatitis</td>
<td align="center" valign="top">Use only with extreme caution.<footnote id="id-9e9f3cd4-3271-4b74-ba7d-a6271dba3e53">Only if other drugs are not available and if clearly indicated. If treatment with life-sustaining drugs that cause pancreatic toxicity is required, suspension of didanosine delayed-release is recommended [<content stylecode="italics">see <linkhtml href="#i4i_section_id_99015e22-6d16-421e-ae75-e05b76b7bd7f">Warnings and Precautions (5.1)</linkhtml>
</content>].</footnote>
</td>
</tr>
<tr id="id_7e34508d-ee2b-4147-bef3-dbbf456e9659">
<td align="left" valign="top">Neurotoxic drugs</td>
<td align="center" valign="top">↑ risk of neuropathy</td>
<td align="center" valign="top">Use with caution.<footnote id="id-a5577fbc-f3d1-4b64-a368-fd02fba29962">
<content stylecode="italics">[See <linkhtml href="#i4i_section_id_0e82732d-340d-497a-9a7e-9fdc8c9b93ac">Warnings and Precautions (5.6)</linkhtml>] </content>
</footnote>
</td>
</tr>
<tr id="id_928bf772-9508-443c-b488-5a3a0318ff5e" stylecode="Botrule">
<td align="left" colspan="3" valign="top">↑ Indicates increase </td>
</tr>
</tbody>
</table>